Search Within

Kenneth Ho-Ming Yu

  1. "Anna Varghese"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (23)
  3. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (50)
  2. Department of Medicine (50)
  3. Gastrointestinal Oncology Service (50)
  4. Solid Tumor Oncology Division (50)
  5. MSK Grad Students (34)
  6. CTCR Scholars (33)

More Groups

People
  1. Anna Varghese (50)
  2. Eileen O'Reilly (50)
  3. Wungki Park (32)
  4. Joanne Chou (21)
  5. David Kelsen (20)
  6. Marinela Capanu (20)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Cancer (5)
  3. Clinical Cancer Research (4)
  4. JNCI: Journal of the National Cancer Institute (3)
  5. Annals of Oncology (2)
  6. JAMA Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. Wiley Blackwell (6)
  3. Oxford University Press (5)
  4. American Association for Cancer Research (4)
  5. Elsevier Inc. (3)
  6. American Medical Association (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of plasma KRAS as a prognostic biomarker in localized pancreas ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Gedvilaite, E.; Chou, J. F.; Capanu, M.; You, D.; Yu, K. H.; Varghese, A. M.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; Tsui, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes
    Journal Article

    Wong, W.; Lowery, M. A.; Berger, M. F.; Kemel, Y.; Taylor, B.; Zehir, A.; Srinivasan, P.; Bandlamudi, C.; Chou, J.; Capanu, M.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
    Review

    Singh, R. R.; Goldberg, J.; Varghese, A. M.; Yu, K. H.; Park, W.; O'Reilly, E. M.
    Cancer Treatment Reviews (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of FOLFIRINOX induction therapy for locally unresectable pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Cohen, N.; McIntyre, C. A.; Goldman, D. A.; Mithat, G.; Sadot, E.; O'Reilly, E.; Varghese, A.; Yu, K.; Balachandran, V. P.; D'Angelica, M. I.; more...
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies
    Meeting Abstract

    O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas
    Meeting Abstract

    Wong, W.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Iacobuzio-Donahue, C. A.; Shia, J.; Klimstra, D.; Allen, P. J.; Lowery, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation
    Meeting Abstract

    Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
    Journal Article

    Glassman, D. C.; Palmaira, R. L.; Covington, C. M.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    BMC Cancer (2018)

    Fulltext@MSK | Save